These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24442858)

  • 61. Management of the refractory aplastic anemia patient: what are the options?
    Marsh JC; Kulasekararaj AG
    Blood; 2013 Nov; 122(22):3561-7. PubMed ID: 24052548
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.
    Kojima S; Horibe K; Inaba J; Yoshimi A; Takahashi Y; Kudo K; Kato K; Matsuyama T
    Br J Haematol; 2000 Oct; 111(1):321-8. PubMed ID: 11091219
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
    Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T
    Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.
    Iftikhar R; Chaudhry QUN; Anwer F; Neupane K; Rafae A; Mahmood SK; Ghafoor T; Shahbaz N; Khan MA; Khattak TA; Shamshad GU; Rehman J; Farhan M; Khan M; Ansar I; Ashraf R; Marsh J; Satti TM; Ahmed P
    Blood Rev; 2021 May; 47():100772. PubMed ID: 33187812
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Diagnosis and treatment for aplastic anemia].
    Usuki K
    Rinsho Ketsueki; 2021; 62(8):922-930. PubMed ID: 34497232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Current Treatment Patterns of Aplastic Anemia in China: A Prospective Cohort Registry Study.
    Zhu XF; He HL; Wang SQ; Tang JY; Han B; Zhang DH; Wu LQ; Wu DP; Li W; Xia LH; Zhu HL; Liu F; Shi HX; Zhang X; Zhou F; Hu JD; Fang JP; Chen XQ; Ye TZ; Liang YM; Jin J; Zhang FK
    Acta Haematol; 2019; 142(3):162-170. PubMed ID: 31091521
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
    Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
    Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of immunosuppressive therapy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria (AA-PNH) syndrome during ongoing eculizumab treatment.
    Asano J; Ueda R; Tanaka Y; Shinzato I; Takafuta T
    Intern Med; 2014; 53(2):125-8. PubMed ID: 24429452
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
    Chen C; Fang JP; Huang SL; Zhong FY
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning.
    Konopacki J; Porcher R; Robin M; Bieri S; Cayuela JM; Larghero J; Xhaard A; Andreoli AL; Dhedin N; Petropoulou A; Rodriguez-Otero P; Ribaud P; Moins-Teisserenc H; Carmagnat M; Toubert A; Chalandon Y; Socie G; Peffault de Latour R
    Haematologica; 2012 May; 97(5):710-6. PubMed ID: 22180425
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of adults with severe aplastic anemia: primary therapy with antithymocyte globulin (ATG) and rescue of ATG failures with bone marrow transplantation.
    Crump M; Larratt LM; Maki E; Curtis JE; Minden MD; Meharchand JM; Lipton JH; Messner HA
    Am J Med; 1992 Jun; 92(6):596-602. PubMed ID: 1605140
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation.
    Tichelli A; de Latour RP; Passweg J; Knol-Bout C; Socié G; Marsh J; Schrezenmeier H; Höchsmann B; Bacigalupo A; Samarasinghe S; Rovó A; Kulasekararaj A; Röth A; Eikema DJ; Bosman P; Bader P; Risitano A; Dufour C;
    Haematologica; 2020 May; 105(5):1223-1231. PubMed ID: 31582549
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
    Liu J; Lu XY; Cheng L; Yang Y; Lin SY; Yin H; Liu XQ; Wu XM; He GS
    Hematology; 2019 Dec; 24(1):492-497. PubMed ID: 31221029
    [No Abstract]   [Full Text] [Related]  

  • 75. [Efficacy of immunosuppressive therapy for children with aplastic anemia].
    Wang YC; Yin CY; Feng L; Wang CM; Ma LN; Wei YW; Sheng GY
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan; 14(1):33-7. PubMed ID: 22289749
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series.
    Martynova A; Chiu V; Mert M; Hermel D; Weitz IC
    Ann Hematol; 2021 Apr; 100(4):933-939. PubMed ID: 33420879
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
    Marotta S; Pagliuca S; Risitano AM
    Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Current insights into the treatments of severe aplastic anemia in China.
    Ye L; Zhang F; Kojima S
    Int J Hematol; 2020 Sep; 112(3):292-299. PubMed ID: 32748215
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antithymocyte globulin combined with cyclosporine A down-regulates T helper 1 cells by modulating T cell immune response cDNA 7 in aplastic anemia.
    Zhu F; Qiao J; Zhong XM; Wu QY; Chen W; Yao Y; Niu MS; Fu CL; Zeng LY; Li ZY; Xu KL
    Med Oncol; 2015 Jul; 32(7):197. PubMed ID: 26049920
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.